Abstract
Abstract Chemotherapy-induced neutropenia (CIN) is a common dose-limiting toxicity in cancer patients undergoing cytotoxic chemotherapy. It is generally understood that myelosuppression is the major mechanism resulting in CIN. However, an excessive extravasation (diapedesis) of neutrophils in response to tissue damage-caused by anti-cancer agents is also a possible mechanism. In this study, we have investigated the effects of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) for the maintenance of circulating neutrophil in the gemcitabine induced neutropenia. In CIN mouse model using anticancer drugs, PLAG effectively protected the loss of circulating neutrophils as similar to CXCR2 antagonist, reparixin. And succeeded in vitro neutrophil migration assay also revealed that chemo-attractive activity of neutrophil induced by treatment of anticancer drugs was completely interrupted by PLAG addition. Chemokine (C-X-C motif) ligand 2 (CXCL2) and CXCL8 were effectively induced by treatment of gemcitabine with dose dependent manner in monocyte cell lines and mainly mediated via the signal transducer and activator of transcription 3 (STAT3) signaling pathway. PLAG effectively attenuated gemcitabine induced CXCL2 and CXCL8 expression via interrupting STAT3 activity and also regulated gemcitabine induced macrophage 1 antigen (MAC-1) and L-selectin expression, which means that PLAG interrupted the acceleration of neutrophil extravasation under CIN. Also we have verified that PLAG analogues and metabolites were not affected on neutrophil migration unlike PLAG, suggesting that acetylated diacylglycerol has a key role to regulate on neutrophil migration. Collectively, modulating effect of PLAG on excessive neutrophil extravasation by chemotherapy via attenuating STAT3/CXCL2(8) pathway could be used as very powerful regimen for preventing of neutropenia during diverse chemotherapy. Citation Format: Yong-Jae Kim, Jinseon Jung, Ha-Reum Lee, Ki-Young Sohn, Heung-Jae Kim, Sun Young Yoon, Jae Wha Kim. PLAG prevents the loss of circulating neutrophils in the chemotherapy induced neutropenia model [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5664. doi:10.1158/1538-7445.AM2017-5664
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.